Ischemic heart disease (IHD) remains the leading cause of death worldwide [
[1]
], regardless of the income level of the country [
- Nowbar A.N.
- Gitto M.
- Howard J.P.
- Francis D.P.
- Al-Lamee R
Mortality from ischemic heart disease.
Circulation. 2019; 12e005375https://doi.org/10.1161/CIRCOUTCOMES.118.005375
[2]
]. Mortality trends for IHD slowly but progressively declined over the last decades
[
- Roth G.A.
- Johnson C.
- Abajobir A.
- Abd-Allah F.
- Abera S.F.
- Abyu G.
- Ahmed M.
- Aksut B.
- Alam T.
- Alam K.
- Alla F.
- Alvis-Guzman N.
- Amrock S.
- Ansari H.
- Ärnlöv J.
- Asayesh H.
- Atey T.M.
- Avila-Burgos L.
- Awasthi A.
- Banerjee A.
- Barac A.
- Bärnighausen T.
- Barregard L.
- Bedi N.
- Belay Ketema E.
- Bennett D.
- Berhe G.
- Bhutta Z.
- Bitew S.
- Carapetis J.
- Carrero J.J.
- Malta D.C.
- Castañeda-Orjuela C.A.
- Castillo-Rivas J.
- Catalá-López F.
- Choi J.-.Y.
- Christensen H.
- Cirillo M.
- Cooper Jr., L.
- Criqui M.
- Cundiff D.
- Damasceno A.
- Dandona L.
- Dandona R.
- Davletov K.
- Dharmaratne S.
- Dorairaj P.
- Dubey M.
- Ehrenkranz R.
- El Sayed Zaki M.
- Faraon E.J.A.
- Esteghamati A.
- Farid T.
- Farvid M.
- Feigin V.
- Ding E.L.
- Fowkes G.
- Gebrehiwot T.
- Gillum R.
- Gold A.
- Gona P.
- Gupta R.
- Habtewold T.D.
- Hafezi-Nejad N.
- Hailu T.
- Hailu G.B.
- Hankey G.
- Hassen H.Y.
- Abate K.H.
- Havmoeller R.
- Hay S.I.
- Horino M.
- Hotez P.J.
- Jacobsen K.
- James S.
- Javanbakht M.
- Jeemon P.
- John D.
- Jonas J.
- Kalkonde Y.
- Karimkhani C.
- Kasaeian A.
- Khader Y.
- Khan A.
- Khang Y.-.H.
- Khera S.
- Khoja A.T.
- Khubchandani J.
- Kim D.
- Kolte D.
- Kosen S.
- Krohn K.J.
- Kumar G.A.
- Kwan G.F.
- Lal D.K.
- Larsson A.
- Linn S.
- Lopez A.
- Lotufo P.A.
- El Razek H.M.A.
- Malekzadeh R.
- Mazidi M.
- Meier T.
- Meles K.G.
- Mensah G.
- Meretoja A.
- Mezgebe H.
- Miller T.
- Mirrakhimov E.
- Mohammed S.
- Moran A.E.
- Musa K.I.
- Narula J.
- Neal B.
- Ngalesoni F.
- Nguyen G.
- Obermeyer C.M.
- Owolabi M.
- Patton G.
- Pedro J.
- Qato D.
- Qorbani M.
- Rahimi K.
- Rai R.K.
- Rawaf S.
- Ribeiro A.
- Safiri S.
- Salomon J.A.
- Santos I.
- Santric Milicevic M.
- Sartorius B.
- Schutte A.
- Sepanlou S.
- Shaikh M.A.
- Shin M.-.J.
- Shishehbor M.
- Shore H.
- Silva D.A.S.
- Sobngwi E.
- Stranges S.
- Swaminathan S.
- Tabarés-Seisdedos R.
- Tadele Atnafu N.
- Tesfay F.
- Thakur J.S.
- Thrift A.
- Topor-Madry R.
- Truelsen T.
- Tyrovolas S.
- Ukwaja K.N.
- Uthman O.
- Vasankari T.
- Vlassov V.
- Vollset S.E.
- Wakayo T.
- Watkins D.
- Weintraub R.
- Werdecker A.
- Westerman R.
- Wiysonge C.S.
- Wolfe C.
- Workicho A.
- Xu G.
- Yano Y.
- Yip P.
- Yonemoto N.
- Younis M.
- Yu C.
- Vos T.
- Naghavi M.
- Murray C
Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990
to 2015.
J Am Coll Cardiol. 2017; 70 (Epub 2017/05/17PubMed PMID: 28527533): 1-25https://doi.org/10.1016/j.jacc.2017.04.052
[1]
]. This gradual decrease may be explained by a reduced impact of some conditions including
smoking and hypertension, by the generally more effective treatment of cardiovascular
risk factors, and finally, by the improvement in the management of acute coronary
syndromes [
- Nowbar A.N.
- Gitto M.
- Howard J.P.
- Francis D.P.
- Al-Lamee R
Mortality from ischemic heart disease.
Circulation. 2019; 12e005375https://doi.org/10.1161/CIRCOUTCOMES.118.005375
[1]
]. Since the release of 2004 Guidelines for the management of patients with ST-elevation
myocardial infarction (STEMI) [
- Nowbar A.N.
- Gitto M.
- Howard J.P.
- Francis D.P.
- Al-Lamee R
Mortality from ischemic heart disease.
Circulation. 2019; 12e005375https://doi.org/10.1161/CIRCOUTCOMES.118.005375
[3]
], primary percutaneous coronary intervention (PCI) have been chosen as the preferred
reperfusion strategy over fibrinolysis, provided that it could be performed in a timely
fashion: 120 min is the maximum allowed from the diagnosis of STEMI to primary PCI
[
- Antman E.M.
- Anbe D.T.
- Armstrong P.W.
- Bates E.R.
- Green L.A.
- Hand M.
- Hochman J.S.
- Krumholz H.M.
- Kushner F.G.
- Lamas G.A.
- Mullany C.J.
- Ornato J.P.
- Pearle D.L.
- Sloan M.A.
- Smith Jr., S.C.
- Alpert J.S.
- Anderson J.L.
- Faxon D.P.
- Fuster V.
- Gibbons R.J.
- Gregoratos G.
- Halperin J.L.
- Hiratzka L.F.
- Hunt S.A.
- Jacobs A.K.
American college of cardiology/American heart association task force on practice G.
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction–executive
summary: a report of the American college of Cardiology/American heart association
task force on practice guidelines (Writing committee to revise the 1999 guidelines
for the management of patients with acute myocardial infarction).
Circulation. 2004; 110 (Epub 2004/08/04PubMed PMID: 15289388): 588-636https://doi.org/10.1161/01.CIR.0000134791.68010.FA
[4]
].- Ibanez B.
- James S.
- Agewall S.
- Antunes M.J.
- Bucciarelli-Ducci C.
- Bueno H.
- Caforio A.L.P.
- Crea F.
- Goudevenos J.A.
- Halvorsen S.
- Hindricks G.
- Kastrati A.
- Lenzen M.J.
- Prescott E.
- Roffi M.
- Valgimigli M.
- Varenhorst C.
- Vranckx P.
- Widimsky P
2017 ESC guidelines for the management of acute myocardial infarction in patients
presenting with ST-segment elevation: the task force for the management of acute myocardial
infarction in patients presenting with ST-segment elevation of the European society
of Cardiology (ESC).
Eur Heart J. 2018; 39 (Epub 2017/09/10PubMed PMID: 28886621): 119-177https://doi.org/10.1093/eurheartj/ehx393
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Mortality from ischemic heart disease.Circulation. 2019; 12e005375https://doi.org/10.1161/CIRCOUTCOMES.118.005375
- Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015.J Am Coll Cardiol. 2017; 70 (Epub 2017/05/17PubMed PMID: 28527533): 1-25https://doi.org/10.1016/j.jacc.2017.04.052
- American college of cardiology/American heart association task force on practice G. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction–executive summary: a report of the American college of Cardiology/American heart association task force on practice guidelines (Writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).Circulation. 2004; 110 (Epub 2004/08/04PubMed PMID: 15289388): 588-636https://doi.org/10.1161/01.CIR.0000134791.68010.FA
- 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of Cardiology (ESC).Eur Heart J. 2018; 39 (Epub 2017/09/10PubMed PMID: 28886621): 119-177https://doi.org/10.1093/eurheartj/ehx393
- Selection of the optimal reperfusion strategy for STEMI: does time matter?The opinions expressed in this article are not necessarily those of the editors of the European heart journal or of the European society of cardiology.Eur Heart J. 2006; 27: 761-763https://doi.org/10.1093/eurheartj/ehi775
- Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction.Circulation. 2004; 109: 1223-1225https://doi.org/10.1161/01.CIR.0000121424.76486.20
- Clinical characteristics and outcome of patients with early (<2h), intermediate (2–4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction.Eur Heart J. 2002; 23 (Epub 2002/04/02PubMed PMID: 11922645): 550-557https://doi.org/10.1053/euhj.2001.2901
- Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.J Am Coll Cardiol. 2003; 42: 991-997https://doi.org/10.1016/S0735-1097(03)00919-7
- System delay and mortality among patients with stemi treated with primary percutaneous coronary intervention.JAMA. 2010; 304 (Epub 2010/08/19PubMed PMID: 20716739): 763-771https://doi.org/10.1001/jama.2010.1139
- Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.Int J Cardiol. 2017; 245: 27https://doi.org/10.1016/j.ijcard.2017.07.039
- Mobile intensive care unit versus hospital walk-in patients, in the treatment of first episode ST- elevation myocardial infarction.Eur. J Int Med. 2019; https://doi.org/10.1016/j.ejim.2019.12.005
- Short- and long-term cause of death in patients treated with primary PCI for STEMI.J Am Coll Cardiol. 2014; 64 (Epub 2014/12/03PubMed PMID: 25457398): 2101-2108https://doi.org/10.1016/j.jacc.2014.08.037
- Association of pre-hospital ECG administration with clinical outcomes in ST-Segment myocardial infarction: a systematic review and meta-analysis.Can J Cardiol. 2016; 32 (Epub 2016/10/07PubMed PMID: 27707525): 1531-1541https://doi.org/10.1016/j.cjca.2016.06.004
- Field triage reduces treatment delay and improves long-term clinical outcome in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.J Am Coll Cardiol. 2009; 54 (Epub 2009/12/05PubMed PMID: 19958965): 2296-2302https://doi.org/10.1016/j.jacc.2009.06.056
- Emergency department bypass for ST-Segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American heart association mission: lifeline program.Circulation. 2013; 128 (Epub 2013/06/22PubMed PMID: 23788525): 352-359https://doi.org/10.1161/circulationaha.113.002339
- Door-to-balloon time and mortality among patients undergoing primary PCI.N Engl J Med. 2013; 369 (Epub 2013/09/06PubMed PMID: 24004117): 901-909https://doi.org/10.1056/NEJMoa1208200
- STEMI time delays: a clinical perspective: editorial comment on the article by Verweij et al.Neth Heart J. 2015; 23 (PubMed PMID: 26187608): 415-419https://doi.org/10.1007/s12471-015-0728-z
- Nonsystem reasons for delay in door-to-balloon time and associated in-hospital mortality: a report from the national cardiovascular data registry.J Am Coll Cardiol. 2013; 61 (Epub 2013/03/19PubMed PMID: 23500264): 1688-1695https://doi.org/10.1016/j.jacc.2012.11.073
- Lower hospital volume is associated with higher in-hospital mortality in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction: a report from the NCDR.Circ Cardiovasc Qual Outcomes. 2013; 6 (Epub 2013/11/07PubMed PMID: 24192572): 659-667https://doi.org/10.1161/circoutcomes.113.000233
- Radial versus femoral approach in STEMI: what do we know so far?.Minerva Cardioangiol. 2016; 64 (Epub 2016/03/05. PubMed PMID: 26934660): 219-237
- 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.J Am Coll Cardiol. 2010; 55 (Epub 2010/05/22PubMed PMID: 20488311): 2383-2389https://doi.org/10.1016/j.jacc.2009.12.054
Article info
Publication history
Published online: February 05, 2020
Accepted:
January 29,
2020
Received:
January 19,
2020
Identification
Copyright
© 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Mobile Intensive Care Unit versus Hospital walk-in patients, in the treatment of first episode ST- elevation myocardial infarctionEuropean Journal of Internal MedicineVol. 73
- PreviewIschemic heart disease (IHD) continues to be a major public health problem worldwide [1]. It generates a huge social impact in terms of disability; potential years of life lost, and constitutes the main cause of mortality in the world [2–4]. Despite the advances in medical health care, the future does not seem too bright [5].
- Full-Text
- Preview